|
US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
|
US4826831A
(en)
|
1983-08-05 |
1989-05-02 |
Pre Jay Holdings Limited |
Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
|
|
CA1306950C
(en)
|
1987-04-10 |
1992-09-01 |
Alec D. Keith |
Buccal administration of estrogens
|
|
US5073374A
(en)
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
CA2011063C
(en)
|
1989-02-28 |
1999-07-06 |
Calum B. Macfarlane |
Nicardipine pharmaceutical composition for parenteral administration
|
|
JPH03237557A
(ja)
|
1990-02-14 |
1991-10-23 |
Oki Electric Ind Co Ltd |
ニューラルネットワークシミュレータ及び計算機システム
|
|
US5340585A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Method and formulations for use in treating benign gynecological disorders
|
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
|
US5468736A
(en)
|
1993-02-25 |
1995-11-21 |
The Medical College Of Hampton Road |
Hormone replacement therapy
|
|
US5895783A
(en)
|
1993-07-16 |
1999-04-20 |
Schering Aktiengesellschaft |
Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
|
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
|
DE4344405C2
(de)
|
1993-12-24 |
1995-12-07 |
Marika Dr Med Ehrlich |
Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
|
|
WO1996003929A1
(en)
|
1994-08-04 |
1996-02-15 |
Biex, Inc. |
Method for prediction of premature delivery using estetrol (e4) as an indicator
|
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
|
FR2772272B1
(fr)
|
1997-12-16 |
2000-01-14 |
Rhone Poulenc Rorer Sa |
Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
|
|
BR9813808A
(pt)
|
1997-12-19 |
2002-05-28 |
Smithkline Beecham Corp |
Processo para produção de comprimidos para dispersão na mordida
|
|
US7815937B2
(en)
|
1998-10-27 |
2010-10-19 |
Biovail Laboratories International Srl |
Quick dissolve compositions and tablets based thereon
|
|
US6180682B1
(en)
|
1999-01-26 |
2001-01-30 |
Virgil A. Place |
Buccal drug delivery system for use in male contraception
|
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
|
US6706700B2
(en)
|
1999-12-02 |
2004-03-16 |
Akzo-Nobel, N.V. |
14β,15β-methylene-17α-hydroxymethyl-androgens
|
|
IL150775A0
(en)
|
2000-01-18 |
2003-02-12 |
Schering Ag |
Drospirenone for hormone replacement therapy
|
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
FR2809619B1
(fr)
|
2000-06-06 |
2004-09-24 |
Pharmatop |
Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
|
|
EP1216713A1
(en)
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Compositions of estrogen-cyclodextrin complexes
|
|
DE60217324T2
(de)
*
|
2001-05-18 |
2007-04-26 |
Pantarhei Bioscience B.V. |
Pharmazeutische zusammensetzung für die hormonersatztherapie
|
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
|
EP1390041B1
(en)
|
2001-05-23 |
2009-11-25 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
|
US7732430B2
(en)
|
2001-05-23 |
2010-06-08 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxilated estrogen for use in hormonal contraception
|
|
ATE254465T1
(de)
|
2001-05-23 |
2003-12-15 |
Pantarhei Bioscience Bv |
Zubereitungen für die hormonale kontrazeption
|
|
WO2002094277A1
(en)
*
|
2001-05-23 |
2002-11-28 |
Pantarhei Bioscience B.V. |
Means and method for hormonal contraception
|
|
US20020193356A1
(en)
|
2001-05-23 |
2002-12-19 |
Van Beek Agatha Antonia Magdalena |
Means and method for hormonal contraception
|
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
ATE347365T1
(de)
|
2001-11-15 |
2006-12-15 |
Pantarhei Bioscience Bv |
Verwendung von öestrogen in kombination mit progestogen für die hormonsubstitutions-therapie
|
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
|
CA2476940C
(en)
|
2002-02-21 |
2011-11-01 |
Bayer Intellectual Property Gmbh |
Pharmaceutical compositions comprising one or more steroids, one or more tetrahydrofolate components and vitamin b12
|
|
US20050147670A1
(en)
*
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
|
CA2489270C
(en)
|
2002-06-11 |
2012-08-07 |
Pantarhei Bioscience B.V. |
A method of treating human skin and a skin care composition for use in such a method
|
|
AU2003274946A1
(en)
|
2002-06-11 |
2003-12-22 |
Pantarhei Bioscience B.V. |
Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
|
|
US9034854B2
(en)
|
2002-07-12 |
2015-05-19 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
|
|
MXPA05002294A
(es)
|
2002-08-28 |
2005-09-12 |
Casper Robert |
Regimen de sustitucion de estrogeno.
|
|
US8987240B2
(en)
|
2002-10-23 |
2015-03-24 |
Pantarhei Bioscience B.V. |
Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
|
|
ES2338781T3
(es)
|
2002-11-05 |
2010-05-12 |
Bayer Schering Pharma Aktiengesellschaft |
Uso de la drospirenona para el tratamiento de una hipertension.
|
|
AU2003279624A1
(en)
|
2002-11-08 |
2004-06-07 |
Pantarhei Bioscience B.V. |
Synthesis of estetrol via estrone derived steroids
|
|
JP2006525306A
(ja)
*
|
2003-04-30 |
2006-11-09 |
デビオファーム ソシエテ アノニム |
ゴナドトロピン・ホルモン放出ホルモンを使用する方法及び組成物
|
|
DK1624878T3
(da)
|
2003-05-22 |
2007-01-08 |
Pantarhei Bioscience Bv |
Anvendelse af præparater som omfatter en östrogen komponent til behandling og forebyggelse af muskel-skelet-smerte
|
|
EP2409690B1
(en)
|
2003-09-29 |
2022-11-09 |
Novo Nordisk Health Care AG |
Improved stability of progestogen formulations
|
|
PL1670440T3
(pl)
|
2003-09-29 |
2014-11-28 |
Novo Nordisk Healthcare Ag |
Preparaty HRT
|
|
JP3841804B2
(ja)
|
2003-10-15 |
2006-11-08 |
富士化学工業株式会社 |
口腔内速崩壊性錠剤用の組成物
|
|
US20050113350A1
(en)
|
2003-11-26 |
2005-05-26 |
Bernd Duesterberg |
Extended use combination comprising estrogens and progestins
|
|
EP1535618A1
(en)
|
2003-11-26 |
2005-06-01 |
Schering Aktiengesellschaft |
Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
|
|
MY151322A
(en)
|
2004-04-30 |
2014-05-15 |
Bayer Ip Gmbh |
Management of breakthrough bleeding in extended hormonal contraceptive regimens
|
|
GB0410616D0
(en)
|
2004-05-13 |
2004-06-16 |
Unilever Plc |
Antiperspirant or deodorant compositions
|
|
PT1755562E
(pt)
|
2004-05-28 |
2013-12-26 |
Richter Gedeon Nyrt |
Contraceptivo contendo ácido fólico
|
|
DE102004026670A1
(de)
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
|
|
EA013211B1
(ru)
|
2004-07-01 |
2010-04-30 |
Лек Фармасьютиклз Д.Д. |
Быстрораспадающаяся диспергирующаяся во рту лекарственная форма и способ ее приготовления
|
|
UA89964C2
(ru)
|
2004-09-08 |
2010-03-25 |
Н.В. Органон |
15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
|
|
EA013867B1
(ru)
|
2005-02-03 |
2010-08-30 |
Никомед Фарма Ас |
Способ получения гранулята, содержащего карбонат кальция
|
|
JP5004236B2
(ja)
*
|
2005-02-09 |
2012-08-22 |
キッセイ薬品工業株式会社 |
口腔内崩壊錠
|
|
IS7724A
(is)
|
2005-03-02 |
2006-09-03 |
Actavis Group |
Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
|
|
UY29527A1
(es)
|
2005-05-13 |
2006-12-29 |
Schering Ag |
Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
|
|
EP1888615B1
(en)
|
2005-05-26 |
2012-05-16 |
Abbott Products GmbH |
17 -hsd1 and sts inhibitors
|
|
KR20080031037A
(ko)
|
2005-06-29 |
2008-04-07 |
와이어쓰 |
결합형 에스트로겐과 바제독시펜의 제형
|
|
US20070048369A1
(en)
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
|
EP1971344B1
(en)
|
2006-01-09 |
2010-09-22 |
Pantarhei Bioscience B.V. |
A method of treating an acute vascular disorder
|
|
CN101378762A
(zh)
|
2006-01-09 |
2009-03-04 |
潘塔希生物科学股份有限公司 |
一种治疗急性血管疾病的方法
|
|
ES2558030T3
(es)
|
2006-03-02 |
2016-02-01 |
Warner Chilcott Company, Llc |
Método anticonceptivo oral multifásico de ciclo prolongado
|
|
ES2659316T3
(es)
|
2006-06-08 |
2018-03-14 |
Allergan Pharmaceuticals International Limited |
Procedimientos para administrar formas de dosificación sólidas de etinilestradiol y profármacos del mismo con biodisponibilidad mejorada
|
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
US20070286819A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
CN101489563A
(zh)
|
2006-07-06 |
2009-07-22 |
拜耳先灵医药股份有限公司 |
用于避孕和预防先天性畸形风险的药物制剂
|
|
DE112007001600A5
(de)
|
2006-07-06 |
2009-04-30 |
Bayer Schering Pharma Aktiengesellschaft |
Pharmazeutische Zusammensetzung zur Kontrazeption und zur Verminderung des Risikos angeborener Fehlbildungen
|
|
CN101541326A
(zh)
|
2006-11-29 |
2009-09-23 |
惠氏公司 |
雌激素/选择性雌激素受体调节剂（serm）和雌激素/孕酮双层药片
|
|
ES2531929T3
(es)
|
2006-12-20 |
2015-03-20 |
Teva Women's Health, Inc. |
Formas de dosificación solidas que se disgregan en la boca que comprenden progestina y métodos para hacer y usar las mismas
|
|
CN101583363B
(zh)
|
2007-01-08 |
2013-08-21 |
潘塔希生物科学股份有限公司 |
治疗或预防雌性哺乳动物不育症的方法和此类方法中使用的药物试剂盒
|
|
KR20090104862A
(ko)
|
2007-01-12 |
2009-10-06 |
와이어쓰 |
정제내 정제 조성물
|
|
EP1972618A1
(en)
|
2007-03-20 |
2008-09-24 |
Nabriva Therapeutics AG |
Pleuromutilin derivatives for the treatment of diseases mediated by microbes
|
|
US8367647B2
(en)
|
2007-06-21 |
2013-02-05 |
Pantarhei Bioscience B.V. |
Treatment of meconium aspiration syndrome with estrogens
|
|
WO2009011576A1
(en)
|
2007-07-19 |
2009-01-22 |
Pantarhei Bioscience B.V. |
Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
|
|
FR2920311B1
(fr)
|
2007-08-31 |
2010-06-18 |
Galenix Innovations |
Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
|
|
JP5399749B2
(ja)
|
2008-03-27 |
2014-01-29 |
沢井製薬株式会社 |
プロトンポンプ阻害剤を含有する被覆微粒子
|
|
PT2262486E
(pt)
|
2008-08-01 |
2013-03-27 |
Tovarna Zdravil D D Novo Mesto Krka |
Composição de quetiapina
|
|
US20110250274A1
(en)
|
2008-09-19 |
2011-10-13 |
Shaked Ze Ev |
Estriol formulations
|
|
CN101780073B
(zh)
|
2009-01-21 |
2013-07-03 |
重庆圣华曦药业股份有限公司 |
非布司他分散片药物及其制备方法
|
|
JP5753661B2
(ja)
|
2009-01-26 |
2015-07-22 |
信越化学工業株式会社 |
低置換度ヒドロキシプロピルセルロース水分散液を用いた湿式造粒打錠法
|
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
|
JP2012521393A
(ja)
|
2009-03-26 |
2012-09-13 |
ロイヤル カレッジ オブ サージェオンズ イン アイルランド |
口腔内分散性錠剤
|
|
KR20120044307A
(ko)
|
2009-06-23 |
2012-05-07 |
바이엘 파마 악티엔게젤샤프트 |
긴급 피임용 제약 조성물
|
|
ITMI20091109A1
(it)
|
2009-06-23 |
2010-12-24 |
Wyeth Corp |
Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione
|
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
|
|
JP5945267B2
(ja)
|
2010-04-12 |
2016-07-05 |
ユニヴェルシテ クロード ベルナール リヨン １ |
有機ケイ素ゾルの急速縮合によって得られるハイブリッド材料の製造方法
|
|
MX356702B
(es)
|
2010-04-15 |
2018-06-11 |
Bayer Ip Gmbh |
Formas de dosificación sólidas orales con dosis muy bajas para la hrt.
|
|
EP2399904A1
(en)
|
2010-05-26 |
2011-12-28 |
Nabriva Therapeutics AG |
Process for the preparation of pleuromutilins
|
|
AR081670A1
(es)
|
2010-06-29 |
2012-10-10 |
Leon Farma Sa Lab |
Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
|
|
US10849857B2
(en)
|
2010-07-28 |
2020-12-01 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
WO2012055840A1
(en)
|
2010-10-28 |
2012-05-03 |
Bayer Pharma Aktiengesellschaft |
Composition and preparation for treatment of dysmenorrhea and menstrual pain and use of a hormonal agent and a zinc salt for treatment of menstrual disorders
|
|
MX365568B
(es)
|
2010-12-02 |
2019-06-07 |
Adare Pharmaceuticals Inc |
Granulos de dispersion rapida, comprimidos de disolucion oral y metodos.
|
|
JP2012240917A
(ja)
|
2011-05-16 |
2012-12-10 |
Zensei Yakuhin Kogyo Kk |
製剤化用微粒子とそれを含む製剤
|
|
WO2012164096A1
(en)
|
2011-06-01 |
2012-12-06 |
Estetra S.A. |
Process for the production of estetrol intermediates
|
|
CL2013003435A1
(es)
|
2011-06-01 |
2014-08-01 |
Estetra Sprl |
Proceso de preparacion de intermediarios de estetrol utilizando catalizadores de paladio y grupos protectores acilantes o sililantes; y uso de dicho proceso para preparar estetrol.
|
|
BR112013030833B1
(pt)
|
2011-06-01 |
2019-09-03 |
Estetra S A |
processo para a preparação de um composto de fórmula (i) e processo para a preparação de estetrol
|
|
HUE025350T2
(en)
|
2011-07-19 |
2016-02-29 |
Pantarhei Bioscience Bv |
Tablets containing dehydroepiandrosterone (DHEA)
|
|
EP2383279A1
(en)
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
|
BR112014003113A2
(pt)
|
2011-08-11 |
2017-03-14 |
Estetra Sprl |
método de contracepção de emergência em uma fêmea mamífero
|
|
BR112014005134A2
(pt)
|
2011-09-16 |
2017-04-18 |
Ferring Bv |
composição farmacêutica de dissolução rápida
|
|
EP2764008B1
(en)
|
2011-10-07 |
2016-08-17 |
Estetra S.P.R.L. |
Process for the production of estetrol
|
|
WO2013090117A1
(en)
|
2011-12-13 |
2013-06-20 |
Arstat, Inc. |
A multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
|
|
EP2653163A1
(en)
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
|
US9808470B2
(en)
|
2012-04-19 |
2017-11-07 |
Universite De Liege |
Estrogenic components for use in the treatment of neurological disorders
|
|
US9238265B2
(en)
|
2012-09-27 |
2016-01-19 |
General Electric Company |
Backstrike protection during machining of cooling features
|
|
WO2014159377A1
(en)
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
|
JP6126456B2
(ja)
|
2013-05-17 |
2017-05-10 |
東和薬品株式会社 |
打錠用顆粒とその製造方法、その打錠用顆粒を用いた口腔内崩壊錠
|
|
US20140341326A1
(en)
|
2013-05-20 |
2014-11-20 |
Qualcomm Incorporated |
Channel estimation with discontinuous pilot signals
|
|
EP3943079A1
(en)
|
2013-05-21 |
2022-01-26 |
Predictive Therapeutics, LLC |
Therapeutic and method of use
|
|
EP3046928B1
(en)
|
2013-09-18 |
2017-02-08 |
Crystal Pharma, S.A.U. |
Process for the preparation of estetrol
|
|
US12274276B2
(en)
|
2013-10-03 |
2025-04-15 |
Altria Client Services Llc |
Dissolvable-chewable tablet
|
|
MX2016006896A
(es)
*
|
2013-12-04 |
2016-08-17 |
Galderma Res & Dev |
Microcapsulas de lipidos que comprenden preferiblemente una substancia activa lipofilica y composicion que las contiene, su metodo de preparacion y su uso en dermatolgia y cosmetica.
|
|
HUE035848T2
(en)
|
2013-12-12 |
2018-05-28 |
Donesta Bioscience B V |
Solid dispensing unit containing an estetrol compound in the mouth
|
|
US10571371B2
(en)
|
2014-08-07 |
2020-02-25 |
Wake Forest University Health Sciences |
Compositions and methods for clearing a biological sample
|
|
ES2957543T3
(es)
|
2014-09-29 |
2024-01-22 |
Univ California |
Composiciones y métodos para mantener la función cognitiva
|
|
CA2986039A1
(en)
|
2015-05-18 |
2016-11-24 |
Agile Therapeutics, Inc. |
Contraceptive compositions and methods for improved efficacy and modulation of side effects
|
|
RS57328B1
(sr)
|
2015-06-18 |
2018-08-31 |
Mithra Pharmaceuticals S A |
Orodisperzibilna dozna jedinica koja sadrži estetrolsku komponentu
|
|
WO2016203044A1
(en)
|
2015-06-18 |
2016-12-22 |
Mithra Pharmaceuticals S.A. |
Orodispersible tablet containing estetrol
|
|
LT3310345T
(lt)
|
2015-06-18 |
2021-06-25 |
Estetra Sprl |
Burnoje disperguojama tabletė, turinti estetrolio
|
|
NZ737945A
(en)
|
2015-06-18 |
2023-06-30 |
Estetra Sprl |
Orodispersible dosage unit containing an estetrol component
|
|
DK3313408T3
(da)
|
2015-06-23 |
2024-01-29 |
Laboratorios Leon Farma Sa |
Drospirenon-baseret svangerskabsforebyggende middel til en kvindelig patient, som lider af overvægt
|
|
CA3041016C
(en)
|
2016-10-28 |
2023-09-05 |
Estetra Sprl |
Method for the management of dysmenorrhea and menstrual pain
|
|
CA3178291A1
(en)
|
2016-08-05 |
2018-04-12 |
Estetra Srl |
Method for the management of dysmenorrhea and menstrual pain
|
|
US20200046729A1
(en)
|
2016-08-05 |
2020-02-13 |
Estetra Sprl |
Methods using combined oral contraceptive compositions with reduced cardiovascular effects
|
|
UA126746C2
(uk)
|
2018-02-07 |
2023-01-18 |
Естетра Спрл |
Композиція контрацептива зі зниженими ефектами щодо серцево-судинної системи
|
|
CR20200486A
(es)
|
2018-04-19 |
2021-01-27 |
Estetra Sprl |
Compuestos y sus usos para aliviar los síntomas asociados a la menopausa
|
|
TWI801561B
(zh)
|
2018-04-19 |
2023-05-11 |
比利時商依思特拉私人有限責任公司 |
化合物及其用於緩解絕經相關症狀的用途
|
|
US10929286B2
(en)
|
2018-06-29 |
2021-02-23 |
Seagate Technology Llc |
Arbitrated management of a shared non-volatile memory resource
|
|
TWI893101B
(zh)
|
2020-04-16 |
2025-08-11 |
比利時商埃斯特拉有限責任公司 |
具有降低之副作用之避孕組成物
|